Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma. (15th November 2020)

• Record Type: Journal Article
• Authors: Bayram, Aysel; Ozturk Sari, Sule; Ozluk, Yasemin; Tas, Faruk; Buyukbabani, Nesimi
• Is Part Of: Journal of cutaneous pathology. Volume 48:Number 4(2021)
• Page Start: 472
• Page End: 478
• Publication Date: 2020-11-15
• Subjects: dual immunohistochemistry -- lymphovascular invasion -- melanoma -- sentinel lymph node; Skin -- Diseases -- Periodicals; Dermatology -- Periodicals; 616
• DOI: 10.1111/cup.13874
• Languages: English
• ISSNs: 0303-6987

Abstract

Abstract: Background: Lymphovascular invasion (LVI) is believed to be the mechanism by which melanoma cells can disseminate to regional lymph nodes and distant sites and may be predictive of adverse outcome. Lymphovascular invasion often difficult to detect on hematoxylin‐eosin (HE) stained sections, are readily identified with dual immunohistochemistry (IHC) for melanocytic and vascular markers. Methods: A total of 100 primary cutaneous malignant melanoma cases that had a Breslow thickness of 1‐4 mm and lacked LVI by conventional HE assessment were included. We compared the LVI detection rates of double staining for CD31/S100 and CD34/S100, and D2‐40/S100, and examined the association of LVI with clinical outcomes. Results: The dual immunohistochemical positivity for CD31/S100, CD34/S100, and D2‐40/S100 were 40(40%), 17(17%) and 35(35%), respectively. On multivariate analysis, LVI was an independent predictor of SLN status. Multivariate analysis revealed that LVI and male gender were independent risk factors for overall survival. Conclusions: The recognition of LVI is improved by dual IHC and predicts SLN metastasis. The detection of LVI using dual IHC, especially by a combination of CD31/S100 and D2‐40/S100 is a useful step that inclusion should be recommended in basic evaluation parameters for cutaneous melanoma.